Hip Replacements; New Depuy Hip Replacement Being Investigated By FDA

Categories: Blog, Medical Malpractice

Hip replacement surgery involves inherent risks, but for those who have all-metal hip replacements, the risks are now even greater.

Last August, all recipients of a DePuy all-metal hip were notified that the company was voluntarily recalling its all-metal hips. Countless people who had received a DePuy hip were in need of revision surgery, which is just as risky as the first procedure. The all-metal hips were experiencing a 13% failure rate despite the fact that they should have lasted approximately 15 years.

In the wake of the recall, lawsuits have been filed by revision patients and others experiencing pain as a result of their DePuy hip. The Food and Drug Administration is now investigating, and has posted a set of web pages to inform the public about the risk posed to those who received a DePuy hip replacement. It also lists symptoms that patients should watch for.

All-metal hips differ from other hips in that they contain no rubber or silicone. If installed incorrectly, or if they fail, themetal surfaces of the ball joint scrape against one another, releasing metal particles. These particles can cause inflammation, pain, bone loss, tissue death, and metal poisoning. The hips must be replaced.

DePuy hip replacement recipients have recourse. Manufacturers may be held liable for product defects and malfunctions if they are the result of negligence and could have been prevented. Some experts believe that the injuries caused by the DePuy hip could have been prevented if they had been properly tested before use. This allegation is most likely at the center of the FDA’s investigation.

Reportedly, DePuy has agreed to cover the costs of monitoring and treatment for those who received the all-metal hip.

If you or someone you know has received a DePuy hip, it would be wise to consult a products liability lawyer who has experience in hip or knee replacement lawsuits to find out if you’re entitled to more compensation.

As the FDA investigates, the evidence will only grow.

From Findlaw,(from material authored by Stephanie Rabiner).

Related Resources:
• FDA Airs Concerns About Hip Joints to Patients (MedPage Today)
• FDA posts public health communication about metal-on-metal hips (ORTHOSuperSite)

For more information on this article, or for a confidential discussion of your personal injury claim, contact Paul  Mitchell, Q.C. at 250-869-1115 (direct line), or at mitchell@pushormitchell.com

Paul Mitchell, Q.C. has extensive experience with brain injury, spinal injury, death claims, and other catastrophic injury claims, as well as medical negligence claims.

He also has extensive experience with hip and knee replacement product liability claims.

He acts for injured clients all over BC and Alberta, and will not act for any insurance company.